NCT00743015View on ClinicalTrials.gov

Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

March 31, 2009

Conditions
Migraine Disorders
Interventions
DRUG

BI 44370 TA tablet

Trial Locations (2)

Unknown

1246.21.32001 Boehringer Ingelheim Investigational Site, Leuven

1246.21.49001 Boehringer Ingelheim Investigational Site, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00743015 - Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks | Biotech Hunter | Biotech Hunter